Summary
Johnson & Johnson (JNJ) announced its fourth quarter and full year 2020 results on January 26, 2021. The filing, an 8-K, primarily serves to attach the accompanying press release and supplementary financial data, detailing the company's performance for the periods ending January 3, 2021. Investors should review the press release for specific sales figures, earnings per share, and segmental performance, which are the core of this disclosure.
Key Highlights
- 1JNJ reported fourth quarter and full year 2020 financial results on January 26, 2021.
- 2The 8-K filing includes a press release announcing these results.
- 3The financial data covers the periods ended January 3, 2021.
- 4Key financial metrics such as sales and earnings are detailed in the press release.
- 5Supplementary sales data and condensed consolidated statements of earnings are provided.
Frequently Asked Questions
The main purpose of this 8-K filing is to publicly disclose Johnson & Johnson's financial results for the fourth quarter and full year ended January 3, 2021, by attaching the official press release and supplementary financial information.
Detailed financial performance information, including sales and earnings, can be found in the press release (Exhibit 99.1) and the unaudited comparative supplementary sales data and condensed consolidated statements of earnings (Exhibit 99.2) attached to this 8-K filing.
The financial data reported covers the fourth quarter and the full year ended January 3, 2021.